A Phase IV Study of Cipro XR in Uncomplicated UTI

PHASE4CompletedINTERVENTIONAL

Enrollment

7,614

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

July 31, 2003

Conditions

Urinary Tract Infections

Interventions

BEHAVIORAL

Cipro XR (Ciprofloxacin, BAYQ3939)

Received Cipro XR (Ciprofloxacin, BAYQ3939) 500 mg once daily for 3 days and brochure about UTI

BEHAVIORAL

Cipro XR (Ciprofloxacin, BAYQ3939)

Received Cipro XR (Ciprofloxacin, BAYQ3939) 500 mg once daily for 3 days; not given brochure about UTI